Invention Grant
- Patent Title: 3-methylcrotonic acid decarboxylase (MDC) variants
-
Application No.: US17029825Application Date: 2020-09-23
-
Publication No.: US11293016B2Publication Date: 2022-04-05
- Inventor: François Stricher , Benoît Villiers
- Applicant: Global Bioenergies
- Applicant Address: FR Evry
- Assignee: Global Bioenergies
- Current Assignee: Global Bioenergies
- Current Assignee Address: FR Evry
- Agency: InHouse Patent Counsel, LLC
- Agent Michael M. Wales
- Priority: EP16168448 20160504,EP16199502 20161118
- Main IPC: C12N9/88
- IPC: C12N9/88 ; C12P5/02

Abstract:
Described are 3-methylcrotonic acid decarboxylase (MDC) variants showing an improved activity in converting 3-methylcrotonic acid into isobutene as well as methods for the production of isobutene using such enzyme variants.
Public/Granted literature
- US20210102186A1 3-METHYLCROTONIC ACID DECARBOXYLASE (MDC) VARIANTS Public/Granted day:2021-04-08
Information query